NCT06221020 To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery
| NCT ID | NCT06221020 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Enhanced Recovery After Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2023-12-12 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2023-12-12 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of pituitary tumors * To sign a written informed consent form Exclusion Criteria: * Diagnosed with other malignant tumors * Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area * Pregnant women * Coagulation disorders or those taking anticoagulant medication * Other central nervous system disorders, alcohol addiction, other addictive drugs, or mental illness that may affect clinical assessment * Deemed unsuitable for surgical treatment or unable to comply with clinical evaluation upon assessment
Contact & Investigator
Hung-Chen Wang, MD, PhD
PRINCIPAL INVESTIGATOR
Chang Gung Memorial Hospital
Frequently Asked Questions
Who can join the NCT06221020 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 75 Years, studying Enhanced Recovery After Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06221020 currently recruiting?
Yes, NCT06221020 is actively recruiting participants. Contact the research team at m82whc@gmail.com for enrollment information.
Where is the NCT06221020 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT06221020 clinical trial?
NCT06221020 is sponsored by Chang Gung Memorial Hospital. The principal investigator is Hung-Chen Wang, MD, PhD at Chang Gung Memorial Hospital. The trial plans to enroll 70 participants.